Nuvation Bio Inc - Rasio nilai perusahaan marang dodolan NUVB

Simbol resmi perusahaan nuvationbio.com (NUVB)

The implementation of "green chemistry" principles to reduce synthesis toxicity is driving interest in Nuvation Bio Inc. (NUVB). This EV/Revenue chart visualizes this demand, where 5718.34 shows the current value of the metric. The asset's price action remains independent of economic cycles, relying instead on the success of clinical trials. Nuvation Bio Inc. (NUVB) is currently scaling targeted therapies following the integration of acquired international clinical programs.

Nuvation Corp (NUVB): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Nuvation Pharma - rincian analitis lan metrik utama (NUVB)

Pambiji fundamental perusahaan:NUVB, nuvationbio.com
Produk sing diprodhuksi Nuvation Bio Inc

For Nuvation Bio Inc. (NUVB), investment attractiveness is based on the retention of rare oncology talent. The EV/Sales trajectory reflects the business value, adjusted for net debt and correlated with annual turnover. This metric allows for an assessment of the real market value of assets without distortions from financial liabilities. This chart reveals the company's resilience to volatility. Low values may signal a risk of liquidity shortages.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Day One Bio DAWN|Nilai perusahaan marang pendapatan MNPR|Multiplikator nilai perusahaan marang pendapatan Inhibrx Biosciences INBX|Nilai perusahaan marang pendapatan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Nilai bisnis marang pendapatan|Heron Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CRBP (Corbus Pharma)|CRDF: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan beyondspringpharma.com (BYSI)|Rasio nilai perusahaan marang pendapatan bioatla.com|LIXT: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales